Back to top

Image: Bigstock

Tenet (THC) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

Read MoreHide Full Article

Tenet Healthcare (THC - Free Report) reported $5.27 billion in revenue for the quarter ended June 2025, representing a year-over-year increase of 3.3%. EPS of $4.02 for the same period compares to $2.31 a year ago.

The reported revenue represents a surprise of +2.43% over the Zacks Consensus Estimate of $5.15 billion. With the consensus EPS estimate being $2.84, the EPS surprise was +41.55%.

While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.

As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.

Here is how Tenet performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
  • Adjusted admissions: 211.52 thousand versus the two-analyst average estimate of 223.82 thousand.
  • Net Operating revenues: $5.27 billion compared to the $5.13 billion average estimate based on four analysts. The reported number represents a change of +3.3% year over year.
  • Net Operating revenues- Ambulatory Care: $1.27 billion versus $1.23 billion estimated by four analysts on average. Compared to the year-ago quarter, this number represents a +11.3% change.
  • Net Operating revenues- Hospital Operations and Services: $4 billion compared to the $3.92 billion average estimate based on four analysts. The reported number represents a change of +1% year over year.
  • Equity in earnings of unconsolidated affiliates: $61 million compared to the $60.53 million average estimate based on four analysts.
  • Adjusted EBITDA- Hospital Operations and Services: $623 million compared to the $505.06 million average estimate based on three analysts.
  • Adjusted EBITDA- Ambulatory Care: $498 million compared to the $496.33 million average estimate based on three analysts.

View all Key Company Metrics for Tenet here>>>

Shares of Tenet have returned +3.3% over the past month versus the Zacks S&P 500 composite's +5.9% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.

See More Zacks Research for These Tickers


Normally $25 each - click below to receive one report FREE:


Tenet Healthcare Corporation (THC) - free report >>

Published in